These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 35274752)
1. Clonidine suppression test for a reliable diagnosis of pheochromocytoma: When to use. Tsiomidou S; Pamporaki C; Geroula A; Van Baal L; Weber F; Dralle H; Schmid KW; Führer D; Unger N Clin Endocrinol (Oxf); 2022 Nov; 97(5):541-550. PubMed ID: 35274752 [TBL] [Abstract][Full Text] [Related]
2. Improved Diagnostic Accuracy of Clonidine Suppression Testing Using an Age-Related Cutoff for Plasma Normetanephrine. Remde H; Pamporaki C; Quinkler M; Nölting S; Prejbisz A; Timmers HJLM; Masjkur J; Fuss CT; Fassnacht M; Eisenhofer G; Deutschbein T Hypertension; 2022 Jun; 79(6):1257-1264. PubMed ID: 35378989 [TBL] [Abstract][Full Text] [Related]
3. ACCURACY OF PLASMA FREE METANEPHRINES IN THE DIAGNOSIS OF PHEOCHROMOCYTOMA AND PARAGANGLIOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS. Chen Y; Xiao H; Zhou X; Huang X; Li Y; Xiao H; Cao X Endocr Pract; 2017 Oct; 23(10):1169-1177. PubMed ID: 28704098 [TBL] [Abstract][Full Text] [Related]
4. Urinary clonidine suppression testing for the diagnosis of pheochromocytoma. Goupil R; Fountoulakis S; Gordon RD; Stowasser M J Hypertens; 2015 Nov; 33(11):2286-93. PubMed ID: 26335433 [TBL] [Abstract][Full Text] [Related]
5. A comparison of plasma-free metanephrines with plasma catecholamines in the investigation of suspected pheochromocytoma. Lee GR; Johnston PC; Atkinson AB; McKillop D; Auld P; Hunter SJ J Hypertens; 2011 Dec; 29(12):2422-8. PubMed ID: 22002333 [TBL] [Abstract][Full Text] [Related]
6. The association between systolic blood pressure reduction during clonidine suppression testing and the decrease in plasma catecholamines and metanephrines. Golani T; Fishman B; Sharabi Y; Olswang-Kutz Y; Leibowitz A; Grossman E; Shlomai G J Clin Hypertens (Greenwich); 2020 Oct; 22(10):1924-1931. PubMed ID: 32882089 [TBL] [Abstract][Full Text] [Related]
7. Clinical diagnosis of pheochromocytoma and paraganglioma-induced secondary hypertension through UPLC-MS/MS analysis of plasma catecholamines and their metabolites. Zhang W; Li X; Li W; Zhang Y; Cai J; Feng S; Sun Z J Clin Hypertens (Greenwich); 2024 Apr; 26(4):416-424. PubMed ID: 38459755 [TBL] [Abstract][Full Text] [Related]
9. Stability and reference intervals of spot urinary fractionated metanephrines and methoxytyramine by tandem mass spectrometry as a screening method for pheochromocytoma and paraganglioma. Wang K; Gao X; Cong H; Zhang W; Shi X; Dai S; Zhou Z Endocrine; 2020 Jul; 69(1):188-195. PubMed ID: 32222878 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic Accuracy of Salivary Metanephrines in Pheochromocytomas and Paragangliomas. Eijkelenkamp K; Osinga TE; van Faassen M; Kema IP; Kerstens MN; Pacak K; Sluiter WJ; Links TP; van der Horst-Schrivers ANA Clin Chem; 2021 Aug; 67(8):1090-1097. PubMed ID: 34096581 [TBL] [Abstract][Full Text] [Related]
11. [Diagnosis of pheochromocytoma and paraganglioma: the clonidine suppression test in patients with borderline elevations of plasma free normetanephrine]. Därr R; Lenders JW; Stange K; Kindel B; Hofbauer LC; Bornstein SR; Eisenhofer G Dtsch Med Wochenschr; 2013 Jan; 138(3):76-81. PubMed ID: 23299341 [TBL] [Abstract][Full Text] [Related]
13. Urinary Free Metanephrines for Diagnosis of Pheochromocytoma and Paraganglioma. Ahn J; Park JY; Kim G; Jin SM; Hur KY; Lee SY; Kim JH Endocrinol Metab (Seoul); 2021 Jun; 36(3):697-701. PubMed ID: 34107605 [TBL] [Abstract][Full Text] [Related]
14. Comparison of plasma metanephrines measured by a commercial immunoassay and urinary catecholamines in the diagnosis of pheochromocytoma. Christensen TT; Frystyk J; Poulsen PL Scand J Clin Lab Invest; 2011 Dec; 71(8):695-700. PubMed ID: 22023043 [TBL] [Abstract][Full Text] [Related]
15. Screening for phaeochromocytoma and paraganglioma: impact of using supine reference intervals for plasma metanephrines with samples collected from fasted/seated patients. Casey R; Griffin TP; Wall D; Dennedy MC; Bell M; O'Shea PM Ann Clin Biochem; 2017 Jan; 54(1):170-173. PubMed ID: 27166307 [TBL] [Abstract][Full Text] [Related]
16. Plasma Metanephrines Yield Fewer False-Positive Results Than Urine Metanephrines in Patients With Obstructive Sleep Apnea. King TFJ; Mok Y; Dacay LM; Wong HS; Hsu PP; Tan A; Wong KM; Saffari SE; Lenders JWM; Puar TH J Clin Endocrinol Metab; 2024 Feb; 109(3):844-851. PubMed ID: 37721483 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors. Procopiou M; Finney H; Akker SA; Chew SL; Drake WM; Burrin J; Grossman AB Eur J Endocrinol; 2009 Jul; 161(1):131-40. PubMed ID: 19383804 [TBL] [Abstract][Full Text] [Related]
18. Study of stability and interference for catecholamines and metanephrines, 3-methoxytyramine: key point of an accurate diagnosis for pheochromocytoma and paraganglioma. Wang K; Gao X; Zhang W; Sun N; Xie L; Cong H; Guo Y; Shi X; Zhou Z Scand J Clin Lab Invest; 2021 Nov; 81(7):564-572. PubMed ID: 34570657 [TBL] [Abstract][Full Text] [Related]
19. Measurement of plasma free metanephrine and normetanephrine by liquid chromatography-tandem mass spectrometry for diagnosis of pheochromocytoma. Lagerstedt SA; O'Kane DJ; Singh RJ Clin Chem; 2004 Mar; 50(3):603-11. PubMed ID: 14726465 [TBL] [Abstract][Full Text] [Related]